Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
US Drug Acq DMAA Stock Upgrade Alert Stuck 20260418 Perfect Moment PMNT Stock 52Week High Bearish Sentiment 20260415 John HPS Expansion Plans Q1 2026 Earnings Report Shattuck Labs STTK Stock High Frequency Skyrockets 20260420 SAJ Saratoga delivers 227 EPS surprise for Q1 2026 shares hold steady in daily trading EBS Emergent BioSolutions reports sharp Q4 2025 EPS miss shares edge down 074 percent on weak results Bristol Myers Squibb BMY Partners With Pfizer to List Blockbuster Anticoagulant Eliquis on Mark Cuban Cost Plus Platform at 345 Monthly KVH Industries KVHI Q1 2026 Earnings Beat Revenue NA EPS 003 Global GIC Q1 2026 Earnings 042 EPS Surges Past 041 Estimates Lowenstein Sandler Strengthens MA Practice with Partner Ivan J Presant Beyond Bitcoin 10 Cryptocurrencies Shaping the Digital Asset Landscape in 2026 VeriSign VRSN Q1 2026 Earnings EPS 234 Beats Estimates LuxExperience LUXE Delivers Q1 2026 Beat EPS 004 vs 007 Expected Alight Expands Health Solutions Network Through New Strategic Partnerships Oil Prices Slide on Reports of Potential Iran Agreement Stock Futures Advance A Divided Fed Holds Rates Steady Amid Policy Disagreement SpaceX Scrubs Starship Test Flight Reschedules for Friday Amid IPO BuildUp Amazon Faces Allegations Over Previously Legal Policy That Generated Millions Robotic Sewing Systems Could Reshape Global Apparel Supply Chains VRTS Q1 2026 Earnings EPS Misses Estimates on Negative Surprise FibroBiologics FBLG Q1 2026 Earnings Narrow EPS Miss as PreRevenue Biotech Continues RD Investment Fractyl Health Inc GUTS Q1 2026 Earnings Narrower Loss Surprises Stock Slides Univest Financial UVSP Q1 2026 Earnings Earnings Beat Estimates by 15 as Net Income Rises Agree Realty Q1 2026 Earnings Modest EPS Beat Amid Stable Operations Teva Pharmaceuticals Advances 235 as Buyers Test Resistance Near 37 United Parks Resorts PRKS Gains 26 as Stock Approaches Key Resistance Level Landmark Bancorp LARK Slides 2 Support and Resistance Levels Under Focus Lionheart Holdings CUB Holds Steady at 1080 as Stock Trades Flat AENTW Warrants Hold Steady at 049 as Support and Resistance Narrow Civista Bancshares CIVB Rises 050 Tests Key Resistance Level at 272 Google Antitrust Scrutiny Defining Market Dominance Remains a Complex Challenge Novartis Raises FullYear Sales and Profit Guidance Signaling Strong Operational Momentum